"10.1371_journal.pone.0090509","plos one","2014-03-05T00:00:00Z","Darin T Okuda; Aksel Siva; Orhun Kantarci; Matilde Inglese; Ilana Katz; Melih Tutuncu; B Mark Keegan; Stacy Donlon; Le H Hua; Angela Vidal-Jordana; Xavier Montalban; Alex Rovira; Mar Tintoré; Maria Pia Amato; Bruno Brochet; Jérôme de Seze; David Brassat; Patrick Vermersch; Nicola De Stefano; Maria Pia Sormani; Daniel Pelletier; Christine Lebrun; on behalf of the Radiologically Isolated Syndrome Consortium (RISC) and Club Francophone de la Sclérose en Plaques (CFSEP)","University of Texas Southwestern Medical Center, Department of Neurology & Neurotherapeutics, Clinical Center for Multiple Sclerosis, Dallas, Texas, United States of America; University of Istanbul, Department of Neurology, Cerrahpasa School of Medicine, Istanbul, Turkey; Mayo Clinic College of Medicine, Department of Neurology, Rochester, Minnesota, United States of America; Mt. Sinai School of Medicine, Department of Neurology, Radiology and Neuroscience, New York, New York, United States of America; Barrow Neurological Institute, Department of Neurology, Phoenix, Arizona, United States of America; Cleveland Clinic Lou Ruvo Center for Brain Health, Department of Neurology, Las Vegas, Nevada, United States of America; MS Center of Catalunya Cemcat and Magnetic Resonance Unit, Vall d′Hebron Hospital, Barcelona, Spain; University of Florence, Department of Neurology, Florence, Italy; Centre Hospitalo Universitaire Bordeaux, Bordeaux, France; Centre Hospitalo Universitaire Strasbourg, Strasbourg, France; Centre Hospitalo Universitaire Purpan, Toulouse, France; Centre Hospitalo Universitaire Salengro, Lille, France; University of Siena, Department of Medicine, Surgery & Neuroscience, Siena, Italy; University of Genoa, Department of Health Sciences (DISSAL), Genoa, Italy; Yale University, Departments of Neurology and Diagnostic Radiology, New Haven, Connecticut, United States of America; Hôpital Pasteur, Service de Neurologie, Nice, France","Membership of the Radiologically Isolated Syndrome Consortium (RISC) and Club Francophone de la Sclérose en Plaques (CFSEP) is provided in the Acknowledgments.","Dr. Okuda reports personal fees for consulting, advisory board, and speaking activities from Acorda Therapeutics, Biogen IDEC, Genzyme, Ipsen Pharmaceuticals, and Teva Neuroscience, outside the submitted work. Professor Siva reports personal fees for consulting and serving on a scientific advisory board from Bayer-Schering AG, Novartis, Biogen IDEC and Allergan within the last year, and travel and registration coverage for congresses or symposia from Bayer-Schering AG, Merck-Serono, Gen Ilac, and Allergan. Professor Siva received research support from Bayer-Schering AG, outside the submitted work. Dr. Kantarci has nothing to disclose. Dr. Inglese reports personal fees from Celgene, and Vaccinex. Dr. Katz reports grants from Acorda Therapeutics and from the National MS Society, outside the submitted work. Dr. Tutuncu has nothing to disclose. Dr. Keegan reports personal fees from eMedicine, Bristol Meyers Squibb, Novartis, Bionest, and grants from Terumo BCT, outside the submitted work. Dr. Donlon has nothing to disclose. Dr. Hua has nothing to disclose. Dr. Vidal-Jordana reports personal fees from EMD Serono, outside the submitted work. Dr. Montalban reports personal fees from Almirall, Bayer, Biogen IDEC, EMD Serono, Merck, Genentech, GeNeuro, Genzyme, Neurotec, Novartis, Sanofi-Aventis, and Teva Neuroscience, outside the submitted work. Dr. Rovira reports personal fees from AdvanceCell Bayer-Schering Pharma, Novartis, OLEA Medical, Sanofi-Aventis, Teva Neuroscience, Biogen IDEC, grants from Siemens AG, outside the submitted work. Dr. Tintoré reports personal fees from Genzyme, Biogen IDEC, Teva Neuroscience, Novartis, Sanofi-Aventis, Bayer, and Merck Serono, outside the submitted work. Dr. Amato reports grants and personal fees from Biogen IDEC, Merck Serono, Bayer-Schering, Teva Neuroscience, Sanofi-Aventis, and Novartis, outside the submitted work. Dr. Brochet reports personal fees from Novartis, Genzyme, and Bayer, grants from Bayer and Teva Neuroscience, Merck-Serono, and Caridian, outside the submitted work. Dr. de Seze has nothing to disclose. Dr. Brassat reports personal fees from Bayer-Schering, Biogen IDEC, Merck-Serono, Novartis, Sanofi-Aventis, and Teva Neuroscience, outside the submitted work. Dr. Vermersch reports grants and personal fees from Biogen IDEC, Sanofi-Aventis, Bayer, Merck-Serono, personal fees from Novartis, GSK, and Almirall, outside the submitted work. Dr. De Stefano reports personal fees from Merck-Serono, Novartis Pharma AG, Teva Neuroscience, Sanofi-Aventis, Bayer-Schering AG, and Biogen IDEC, outside the submitted work. Dr. Sormani reports personal fees from Biogen IDEC, Merck-Serono, Actelion, Synthon, and Allozyne, outside the submitted work. Dr. Pelletier reports personal fees from Teva Neuroscience, Biogen IDEC, and Roche, grants from Biogen IDEC, outside the submitted work. Dr. Lebrun has nothing to disclose. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","03","Darin T Okuda","DTO",23,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
